XML 24 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Statement of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Subordinate Voting Shares (as converted)
Share Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings (Deficit)
Non- Controlling Interest
Beginning balance (in shares) at Dec. 31, 2021   324,312,662        
Beginning balance at Dec. 31, 2021 $ 1,481,806   $ 1,535,765 $ 0 $ (55,235) $ 1,276
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   3,320,195        
Share-based compensation 43,343   43,343      
Issuance of shares in conjunction with acquisitions (in shares)   7,039,977        
Issuance of shares in conjunction with acquisitions 41,914   41,914      
Noncontrolling interest adjustment for change in ownership (1,567)         (1,567)
Foreign Currency Translation Adjustment (8)     (8)    
Contingent consideration & other adjustments to purchase accounting (in shares)   5,310,540        
Contingent consideration & other adjustments to purchase accounting 44,935 $ 44,935        
Net Income (Loss) (268,873)       (269,164) 291
Ending balance (in shares) at Dec. 31, 2022   339,983,374        
Ending balance at Dec. 31, 2022 1,341,550   1,665,957 (8) (324,399) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   1,636,937        
Share-based compensation 13,273   13,273      
Issuance of shares to relieve liability obligations, net (in shares)   828,239        
Issuance of shares to relieve liability obligations, net 2,610   2,610      
Foreign Currency Translation Adjustment (5)     (5)    
Contingent consideration & other adjustments to purchase accounting (in shares)   1,625,546        
Net Income (Loss) (117,348)       (117,348)  
Ending balance (in shares) at Dec. 31, 2023   344,074,096        
Ending balance at Dec. 31, 2023 1,240,080   1,681,840 (13) (441,747) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   3,312,471        
Share-based compensation 16,752   16,752      
Issuance of shares in conjunction with acquisitions (in shares)   10,416,041        
Issuance of shares in conjunction with acquisitions 34,453   34,453      
Foreign Currency Translation Adjustment 18     18    
Contingent consideration & other adjustments to purchase accounting (in shares)   944,682        
Contingent consideration & other adjustments to purchase accounting 2,730 $ 2,730        
Distributions paid to non-controlling interest holders (1,355)         (1,355)
Net Income (Loss) (341,859)       (341,859)  
Ending balance (in shares) at Dec. 31, 2024   358,747,290        
Ending balance at Dec. 31, 2024 $ 950,819   $ 1,735,775 $ 5 $ (783,606) $ (1,355)